Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Malignant neoplasm of pancreas

Known as: boesartige Neubildung Pankreas, ONDARTET SVULST BUKSPYTTKJERTELEN, Cancer of the Pancreas 
A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003
National Institutes of Health

Related topics

Related topics

16 relations
Exocrine pancreasGastrointestinal carcinomaGastrointestinal systemLI-FRAUMENI SYNDROME 1
Expand

Broader (3)

Gastrointestinal NeoplasmsPancreasPancreatic Neoplasm

Narrower (2)

Pancreatic Endocrine Carcinomacarcinoma of head of pancreas

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.
Importance Patients with locally advanced pancreatic cancer have historically poor outcomes. Evaluation of a total neoadjuvant… Expand
Is this relevant?
Review
2019
Review
2019
A Review of Curcumin and Its Derivatives as Anticancer Agents
Cancer is the second leading cause of death in the world and one of the major public health problems. Despite the great advances… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 2
Is this relevant?
Review
2019
Review
2019
Luteolin, a flavonoid, as an anticancer agent: A review.
Many food-derived phytochemicals and their derivatives represent a cornucopia of new anti-cancer compounds. Luteolin (3,4,5,7… Expand
Is this relevant?
Review
2019
Review
2019
New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis
Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is one of the most abundant, long non-coding RNAs (lncRNAs) in… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2019
Review
2019
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
PURPOSE An ASCO provisional clinical opinion (PCO) offers timely clinical direction to ASCO's membership and other health care… Expand
Is this relevant?
Review
2018
Review
2018
Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations: 2018
BackgroundThis is the fourth updated Enhanced Recovery After Surgery (ERAS®) Society guideline presenting a consensus for optimal… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2018
Review
2018
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer.
RAS genes (HRAS, KRAS, and NRAS) comprise the most frequently mutated oncogene family in human cancer. With the highest RAS… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2018
Review
2018
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma risk, diagnostics, treatment and outcomes… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2017
Review
2017
Pancreatic Cancer Chemoresistance to Gemcitabine
Pancreatic ductal adenocarcinoma (PDAC), commonly referred to as pancreatic cancer, ranks among the leading causes of cancer… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
PURPOSE Most patients with advanced pancreas cancer experience pain and must limit their daily activities because of tumor… Expand
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • table 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE